about
Regulation of germinal center B-cell differentiationB Cells and Functional Antibody Responses to Combat InfluenzaTreatment of spinal cord injury with intravenous immunoglobulin G: preliminary evidence and future perspectivesCross-presentation of IgG-containing immune complexesMemory B cells in transplantationThe Role of FcRn in Antigen PresentationUnraveling effector functions of B cells during infection: the hidden world beyond antibody productionImmune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesArtery Tertiary Lymphoid Organs Control Multilayered Territorialized Atherosclerosis B-Cell Responses in Aged ApoE-/- Mice.Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to InfluenzaB cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccinationFcγ receptor expression on splenic macrophages in adult immune thrombocytopenia.Polymorphisms and interspecies differences of the activating and inhibitory FcγRII of Macaca nemestrina influence the binding of human IgG subclasses.γδTFH cells promote B cell maturation and antibody production in neuroblastoma.Effects of resveratrol and essential oils on growth performance, immunity, digestibility and fecal microbial shedding in challenged piglets.Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis.The role of Fc receptors in HIV infection and vaccine efficacy.Porcine FcγRIIb mediates enhancement of porcine reproductive and respiratory syndrome virus (PRRSV) infection.Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in childreFcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo.Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccinesNeutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success.Terminating the immune responseIgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c miceTargeting B cell responses in universal influenza vaccine design.Anti-Ganglioside Antibodies Induce Nodal and Axonal Injury via Fcγ Receptor-Mediated Inflammation.Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivoProtection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs.Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans.Overexpression of Bovine FcRn in Mice Enhances T-Dependent Immune Responses by Amplifying T Helper Cell Frequency and Germinal Center Enlargement in the Spleen.Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.Origin of immunoglobulin isotype switching.Immunogenicity of Isogenic IgG in Aggregates and Immune Complexes.The neutralizing role of IgM during early Chikungunya virus infectionBench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspectiveA new synthesis for antibody-mediated immunity.Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice.In-depth characterization of N-linked oligosaccharides using fluoride-mediated negative ion microfluidic chip LC-MSPeptidoglycan-linked protein A promotes T cell-dependent antibody expansion during Staphylococcus aureus infectionViraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.
P2860
Q26766726-88121923-8704-474C-8C55-2D0D851E908EQ26801639-92708EB5-13C9-496D-BB97-2115663BD52BQ26822442-E4815F18-576B-42C0-BBC6-FD21D5783F23Q26825801-46CF9ADE-02B9-4DDA-A238-4633A1E877CCQ26829296-A71BE39F-69BC-4623-A436-8EB6D803693EQ26852988-6117B1CA-E09B-4B16-8551-7CA15112079DQ27010202-DC6DDC90-8D9C-4E7A-9DC3-36F73787792AQ28069362-8FA2F0EC-D324-4E15-A709-ABF872193772Q30276940-14894D9E-FD4B-4E19-B51A-D0FFA0C0FC00Q30389700-8B6D7E8C-54BF-429C-BA23-DE3B16299FA1Q30429248-A205AF4E-961F-460F-8898-B7C7317E0318Q33438855-5BC9237C-E8C2-47AC-BC1C-25D3DE0A589FQ33842408-4B9220E6-CA1C-460B-88CB-89DE236D7D4CQ33882452-1B9286EE-AD40-4789-A799-0D4219BCE742Q33885627-69921FD3-1824-4116-979B-B71B2C210C6DQ33926907-C65CCE9B-3F3C-4B21-841C-9866D1ADFCDBQ33997395-929B417D-334D-4F77-875B-C17D2651EE67Q34119043-71BB81D3-39CD-4B87-AB97-0713E2C15A4DQ34283944-2A22B9D8-E469-40D0-87DA-D5D4E20334DAQ34320482-D5932C52-B5BD-4156-83CB-DCB2CC08E6AFQ34354440-15972F98-F4F9-4E8E-986A-A2069B75427DQ34550046-B1170A29-B09F-49CB-AC96-7AE148DB0258Q35090375-85097A53-1F62-47D1-87EE-93B8A2378E16Q35400161-0E2A7DE3-7F7D-4683-8DB9-36A505F367CCQ35540405-52B117F7-76D8-4778-BFED-BA1F0E9C2E15Q35547885-64F4AB3F-077E-4424-B929-52C67F34FFF1Q35558688-7C2E31DB-DE50-4D5C-A3B9-46F8B88C9C9DQ35590264-E12AEAAF-6365-46E8-918E-30B1EB6D6B98Q35826280-8240CBE7-8A64-4843-82B7-8760F855AACDQ35866344-7AB6EF28-CCC5-4A76-8C48-2486F1794B35Q35866472-8400B743-8E53-4306-98E2-3AEE8B383C6DQ35989631-3B980ED8-B82C-4A5F-ABAF-710C51C11D5FQ36257660-CF28AD9B-3571-448B-BB69-C7DCD76B599EQ36275851-5F6097E8-C5FE-4984-8B0D-F8C8D91927BDQ36646072-6034BB8F-E1A7-47BF-9D45-AC735F55B3FFQ36660720-FC8C9969-9180-4A05-9D39-3492801C30DBQ36675017-1DDBC72A-AD05-4D1A-B514-CD8214898010Q36704033-D3E41B15-240E-436E-905C-B23BA0BF81BCQ36930930-DD784A27-2669-4108-95D5-2029FFCDEB7BQ36961578-1698969F-84A1-45DD-95F0-99974C3CBF76
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antibody-mediated modulation of immune responses.
@en
Antibody-mediated modulation of immune responses.
@nl
type
label
Antibody-mediated modulation of immune responses.
@en
Antibody-mediated modulation of immune responses.
@nl
prefLabel
Antibody-mediated modulation of immune responses.
@en
Antibody-mediated modulation of immune responses.
@nl
P2860
P1476
Antibody-mediated modulation of immune responses
@en
P2093
Jeffrey V Ravetch
P2860
P304
P356
10.1111/J.1600-065X.2010.00910.X
P577
2010-07-01T00:00:00Z